PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double-blind, placebo-controlled study

BJU International

Volumn 103, Issue 7, 2009, Pages 940-949

  Dinsmore, W Wallace ^a   Wyllie, Michael G ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b Plethora Solutions Ltd   (United Kingdom)

Author keywords

Lidocaine; Premature ejaculation; Prilocaine; PSD502; TEMPE; Topical treatment

Indexed keywords

ANTIDEPRESSANT AGENT; EMLA; LOCAL ANESTHETIC AGENT; PLACEBO; PSD 502; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AEROSOL; AGED; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION; ERECTILE DYSFUNCTION; ETHNICITY; GENITAL BURNING SENSATION; GENITAL ERYTHEMA; HETEROSEXUAL MALE; HETEROSEXUALITY; HUMAN; HYPESTHESIA; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGASM; PHASE 3 CLINICAL TRIAL; PREMATURE EJACULATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SKIN DISEASE; SKIN IRRITATION; TONSILLITIS; VAGINAL BURNING SENSATION; VULVOVAGINAL DISCOMFORT;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANESTHETICS, LOCAL; COITUS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EJACULATION; EUROPE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRILOCAINE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 62149120886     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08456.x     Document Type: Article

References (25)

1. McMahon CG, Althof S, Waldinger MD et al. An evidence-based definition of lifelong premature ejaculation. Report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. BJU Int 2008 102 : 338 50
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999 281 : 537 44
3. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998 15 : 519 24
4. Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in 'normal' couples. N Engl J Med 1978 299 : 111 5
5. Reading AE, Wiest WM. An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav 1984 13 : 69 83
6. Rowland D, Perelman M, Althof S et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004 1 : 225 32
7. Powell JA, Wyllie MG. 'Up and coming' treatments for premature ejaculation: progress towards an approved therapy. Int J Impot Res 2009 Jan 15. [Epub ahead of print]
8. Morales A, Barada J, Wyllie MG. A review of the current status of topical treatments for premature ejaculation. BJU Int 2007 100 : 493 501
9. Shindel A, Nelson C, Brandes S. Urologist practice patterns in the management of premature ejaculation: a nationwide survey. J Sex Med 2008 5 : 199 205
10. Henry R, Morales A, Wyllie MG. TEMPE: topical eutectic-like mixture for premature ejaculation. Expert Opin Drug Deliv 2008 5 : 251 61
11. Dinsmore WW, Hackett G, Goldmeier D et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int 2007 99 : 369 75
12. Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res 2003 15 : 277 81
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR, 4th edn. test revision. Washington, DC : American Psychiatric Association, 2000
14. US FDA. Draft Guidance for Industry, Patient Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available at: http://www.fda.gov/cder/guidance/5460dft.pdf. Accessed January 2009
15. Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med 2006 3 : 465 75
16. Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. BJU Int 2008 103 : 358 64
17. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11 : 319 26
18. Wiens BL. A fixed sequence Bonferroni procedure for testing multiple endpoints. Pharm Stat 2003 2 : 211 5
19. Patrick DL, Althof SE, Pryor JL et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2005 2 : 358 67
20. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005 2 : 492 7
21. Safarinejad MR. Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Neuropsychopharmacology 2008 33 : 1259 65
22. Althof SE, Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 2007 34 : 581 9
23. Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. BJU Int 2008 102 : 824 8
24. Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004 46 : 510 5
25. Pryor JL, Althof SE, Steidle C et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006 368 : 929 37